Patent · US Active

Process for making nucleoside phosphoramidate compounds

US10251903B2 · kind B2 · utility

1Cited by
2References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 20, 2015
Grant dateApr 9, 2019
Priority date
Expiry dateOct 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08K2003/0893
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to a process for making Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.